Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study-Reference-Cited by-同舟云学术

Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study

Published:2021-01 Issue:1 Volume:8 Page:e55-e66
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

den Boer Monique L,Cario Gunnar,Moorman Anthony V,Boer Judith M,de Groot-Kruseman Hester A,Fiocco Marta,Escherich Gabriele,Imamura Toshihiko,Yeoh Allen,Sutton Rosemary,Dalla-Pozza Luciano,Kiyokawa Nobutaka,Schrappe Martin,Roberts Kathryn G,Mullighan Charles G,Hunger Stephen P,Vora Ajay,Attarbaschi Andishe,Zaliova Marketa,Elitzur Sara,Cazzaniga Giovanni,Biondi Andrea,Loh Mignon L,Pieters Rob

Publisher

Elsevier BV

Subject

Hematology

Reference32 articles.

1. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study;Den Boer;Lancet Oncol,2009

2. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia;Mullighan;N Engl J Med,2009

3. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia;Roberts;Cancer Cell,2012

4. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL;van der Veer;Blood,2013

5. Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia;Boer;Oncotarget,2017

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study;Leukemia;2024-09-11

2. Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB‐positive acute lymphoblastic leukemia patients: A retrospective multicenter study;Cancer;2024-08-13

3. SOHO State of the Art Updates and Next Questions | Approach to BCR::ABL1-Like Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-08

4. Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction;Leukemia;2024-07-05

5. Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain;Blood;2024-05-23